Business News›Markets›Stocks›News›Glenmark Pharmaceuticals to sell 75% stake in Glenmark Life Sciences to Nirma for Rs 5,652 cr
Glenmark Pharmaceuticals to sell 75% stake in Glenmark Life Sciences to Nirma for Rs 5,652 cr
Glenmark Pharmaceuticals has received board approval to sell 75% stake in subsidiary Glenmark Life Sciences to Nirma Ltd for Rs 5,652 crore.
Read more on
01:24- 01:56
- 03:49
- 03:11
- 03:17
- 01:07
Stocks in focus: HFCL, Infosys and more
Views: 854 - 01:14
Who is a retail investor in an IPO?
Views: 564 - 01:53
- 01:13
- 12:08
- 03:12
- 01:52
- 03:15
- 03:43
- 02:10
Stocks in focus: IOC, HDFC Bank and more
Views: 1768 - 00:57
What is an NII in an IPO?
Views: 849 - 01:46
- 02:25
- 03:06
- 01:23
- 04:40
- 02:19
- 04:51
- 01:54
- 01:43
- 00:54
- 03:46
- 01:10
What is Intraday trading?
Views: 946 - 01:36
- 02:46
- 02:25
- 02:06
What is CAGR? | ETMarkets Decoder
Views: 572 - 03:46
- 02:40
- 04:00
- 01:21
- 03:56
- 09:39
- 02:54
- 08:24
